BioMotiv LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BioMotiv LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011903
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioMotiv LLC (BioMotiv) is a development company specializes in the licensing and development of therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. The company in association with The Harrington Project for Discovery & Development accelerates discoveries from research institutions into therapeutics for patients. It provides operating platform including legal, business development, financial, IT, and administrative support for companies to focus on their pharmaceutical programs. BioMotiv carries out its activities in collaboration with contract research organizations, investment, and pharmaceutical partners for technology development. The company has partnership with Takeda Pharmaceutical Company, Biogen, Arix Bioscience and Charles River Laboratories among others. BioMotiv is headquartered in Cleveland, Ohio, the US.

BioMotiv LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioMotiv LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioMotiv LLC, Medical Devices Deals, 2011 to YTD 2017 9
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioMotiv LLC, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Allinaire Therapeutics Raises Funds in Seed Financing 12
Allinaire Therapeutics Raises USD1 Million in Venture financing 13
BioMotiv Raises Additional USD30.5 Million in Venture Financing 14
BioMotiv Raises Additional USD4.8 Million in Venture Financing 15
Orca Pharma Raises USD1.3 Million in Venture Financing 16
Orca Pharma Raises Funds through Venture Financing 17
BioMotiv Raises US$25 Million In Venture Financing 18
BioMotiv Raises US$21 Million In Series A Financing 19
Partnerships 20
Charles River Labs Enters into Agreement with BioMotiv 20
BioMotiv Forms Joint Venture with Rutgers University 21
BioMotiv Expands its Agreement with Biogen 22
BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture 23
Licensing Agreements 24
BioAtla Enters Into Licensing Agreement With BioMotiv 24
Sujana Biotech Enters into Licensing Agreement with Case Western Reserve University 25
Equity Offering 26
BioMotiv to Raise up to USD25 Million in Private Placement of Shares 26
Charles River Labs to Invest USD10 Million in BioMotiv 27
Acquisition 28
Takeda Pharma Acquires Minority Stake in BioMotiv for USD25 Million 28
BioMotiv LLC – Key Competitors 29
BioMotiv LLC – Key Employees 30
BioMotiv LLC – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 31
Recent Developments 32
Strategy And Business Planning 32
Mar 16, 2017: Nynex Therapeutics Launched to Target Oncogenic Proteins in the Treatment of Cancer 32
May 02, 2016: Allinaire Therapeutics, a new Biotechnology Start-Up, Launches to Combat Lung Diseases 33
Feb 29, 2016: Z53 Therapeutics, A New Oncology Start-Up, Launches to Combat Cancer-Associated Mutation 34
Government and Public Interest 35
Mar 29, 2016: Sujana Biotech Announces Funding from National Heart Lung and Blood Institute 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
BioMotiv LLC, Pharmaceuticals & Healthcare, Key Facts 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioMotiv LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioMotiv LLC, Deals By Therapy Area, 2011 to YTD 2017 8
BioMotiv LLC, Medical Devices Deals, 2011 to YTD 2017 9
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Allinaire Therapeutics Raises Funds in Seed Financing 12
Allinaire Therapeutics Raises USD1 Million in Venture financing 13
BioMotiv Raises Additional USD30.5 Million in Venture Financing 14
BioMotiv Raises Additional USD4.8 Million in Venture Financing 15
Orca Pharma Raises USD1.3 Million in Venture Financing 16
Orca Pharma Raises Funds through Venture Financing 17
BioMotiv Raises US$25 Million In Venture Financing 18
BioMotiv Raises US$21 Million In Series A Financing 19
Charles River Labs Enters into Agreement with BioMotiv 20
BioMotiv Forms Joint Venture with Rutgers University 21
BioMotiv Expands its Agreement with Biogen 22
BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture 23
BioAtla Enters Into Licensing Agreement With BioMotiv 24
Sujana Biotech Enters into Licensing Agreement with Case Western Reserve University 25
BioMotiv to Raise up to USD25 Million in Private Placement of Shares 26
Charles River Labs to Invest USD10 Million in BioMotiv 27
Takeda Pharma Acquires Minority Stake in BioMotiv for USD25 Million 28
BioMotiv LLC, Key Competitors 29
BioMotiv LLC, Key Employees 30
BioMotiv LLC, Subsidiaries 31
BioMotiv LLC, Joint Venture 31

★海外企業調査レポート[BioMotiv LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chubu Electric Power Co Inc (9502):石油・ガス:M&Aディール及び事業提携情報
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity using hydro, thermal, nuclear and renewable sources. Chubu has interests in upstream and midstream energy fields. It …
  • Flotek Industries Inc (FTK):企業の財務・戦略的SWOT分析
    Summary Flotek Industries Inc (Flotek) is a developer of chemistry based technology solutions for energy, industrial and consumer applications. The company offers stimulation chemistry, cementing chemistry, improved oil recovery chemistry, drilling fluid additives, and coil tubing chemistry. Its sti …
  • Key Energy Services, Inc.:企業の戦略・SWOT・財務情報
    Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The GPT Group:企業のM&A・事業提携・投資動向
    The GPT Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The GPT Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • RPP Infra Projects Ltd (RPPINFRA):企業の財務・戦略的SWOT分析
    RPP Infra Projects Ltd (RPPINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cardtronics UK Limited:企業の戦略・SWOT・財務情報
    Cardtronics UK Limited - Strategy, SWOT and Corporate Finance Report Summary Cardtronics UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The Better Drinks Co Limited:企業の戦略・SWOT・財務情報
    The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report Summary The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Span Diagnostics Ltd (524727)-医療機器分野:企業M&A・提携分析
    Summary Span Diagnostics Ltd (SPAN) is a medical equipment company that develops and manufactures diagnostic products for healthcare markets. The company’s products include reagents, antibiotic disc and instruments. It offers reagents such as glucose, microprotein, amylase, calcium, chloride, uric a …
  • PacWest Bancorp:企業の戦略・SWOT・財務情報
    PacWest Bancorp - Strategy, SWOT and Corporate Finance Report Summary PacWest Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Genesis Energy LP (GEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Genesis Energy LP (Genesis) is a midstream oil and gas company. The company provides services such as offshore pipeline transportation, refinery services, marine transportation, and onshore facilities and transportation. It purchases, transports, stores, blends, and markets crude oil and ref …
  • Hargreaves Services Plc:企業の戦略・SWOT・財務情報
    Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Enel SpA (ENEL):企業の財務・戦略的SWOT分析
    Enel SpA (ENEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Coro Mining Corp:企業の戦略・SWOT・財務情報
    Coro Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Coro Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Jabil Inc (JBL):企業の財務・戦略的SWOT分析
    Jabil Inc (JBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • ENAMINE Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Enamine Ltd (Enamine) is a provider of screening and drug discovery services. The company’s products include building blocks and intermediates, screening compounds, real database, compound libraries, fragment library, tangible building blocks, materials chemistry and scaffolds. It offers ser …
  • JSFC Sistema (AFKS):企業の財務・戦略的SWOT分析
    JSFC Sistema (AFKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • NanoVibronix Inc (NAOV)-医療機器分野:企業M&A・提携分析
    Summary NanoVibronix Inc (NanoVibronix) is a medical device company that offers therapeutic ultrasound technology solutions. The company offers clinical applications such as catheter related injury and its complications, pain and soft tissue healing. It offers electronic unit that uses disposable pa …
  • Consolidated Edison Inc (ED)-エネルギー分野:企業M&A・提携分析
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • Intercept Pharmaceuticals Inc (ICPT):企業の財務・戦略的SWOT分析
    Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tanzania Electric Supply Co Ltd:企業の戦略的SWOT分析
    Tanzania Electric Supply Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆